undamentalytics Newsletter
Sign in

Phreesia, Inc. income statement

In fiscal 2026, Phreesia, Inc. reported revenue of $481m, up 14.5% on the year before, operating income of −$6.6m (a -1.4% margin) and net income of $2.3m, or $0.04 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Jan 20182019Jan 20192020Jan 20202021Jan 20212022Jan 20222023Jan 20232024Jan 20242025Jan 20252026Jan 2026LTMJul 2026
Revenue80100125149213281356420481508
Research and development111419235291112117121116
Selling and marketing2526324310615114712110098
General and administrative19203040698080778079
Operating income−15−9−15−26−117−177−136−58−713
Interest expense—4321122710
Net interest income−4−4−2−2−112———
Income before tax−18−15−22−27−118−176−135−56−93
Income tax00−200023−11−8
Net income−18−15−20−27−118−176−137−59210
Diluted EPS−$12.40−$12.27−$2.25−$0.69−$2.37−$3.36−$2.51−$1.02$0.04$0.17
Diluted shares (average)3m4m41m40m50m52m55m58m61m62m
EBITDA−52−1−10−96−151−107−302550

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: PHR vs WGSDOCS vs PHRGDRX vs PHR

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Phreesia, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Phreesia, Inc.